financetom
Business
financetom
/
Business
/
Expedia Q4 Non-GAAP Earnings, Revenue Rise; Quarterly Dividend Reinstated -- Shares Up After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expedia Q4 Non-GAAP Earnings, Revenue Rise; Quarterly Dividend Reinstated -- Shares Up After Hours
Feb 6, 2025 1:41 PM

04:19 PM EST, 02/06/2025 (MT Newswires) -- Expedia ( EXPE ) late Thursday reported Q4 non-GAAP net income of $2.39 per diluted share, up from $1.72 a year earlier.

Analysts polled by FactSet, on average, expected $2.09.

Revenue for the quarter ended Dec. 31 was $3.18 billion, compared with $2.89 billion a year earlier.

Analysts expected $3.07 billion.

The online travel company also reinstated a quarterly dividend of $0.40 per share, payable March 27 to shareholders of record on March 6.

Expedia ( EXPE ) shares were rising nearly 8% in extended session.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook
Jul 17, 2024
08:32 AM EDT, 07/17/2024 (MT Newswires) -- Prologis ( PLD ) reported Q2 core funds from operations Wednesday of $1.34 per diluted share, compared with $1.83 a year earlier. Analysts polled by Capital IQ expected $1.07. Total revenue for the quarter ended June 30 was $2.01 billion, down from about $2.45 billion a year earlier. Analysts surveyed by Capital IQ...
Northern Trust's profit surges on fee income boost, accounting gain
Northern Trust's profit surges on fee income boost, accounting gain
Jul 17, 2024
(Reuters) - Asset and wealth manager Northern Trust ( NTRS ) posted a more than two-fold jump in second-quarter profit on Wednesday, thanks to higher fee income and an accounting gain of $878.4 million from a stock exchange deal with Visa. Hopes of a soft landing for the U.S. economy and investor frenzy around artificial intelligence have lifted the stock...
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday it has received regulatory clearance from the Netherlands' ethics authority to begin human testing of its IMP761 potential autoimmune disease treatment. Immutep ( IMMP ) describes IMP761 as a LAG-3 agonist antibody to potentially treat rheumatoid arthritis, type 1 diabetes, and multiple sclerosis, among other autoimmune diseases....
BioCardia Receives Patent for Morph DNA Transseptal Delivery
BioCardia Receives Patent for Morph DNA Transseptal Delivery
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology. The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said. BioCardia's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved